| Patents for C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups (27,160) |
|---|
| 04/27/2005 | CN1610547A N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor |
| 04/27/2005 | CN1198834C Water soluble produgs of hindered alcohols or phenols |
| 04/26/2005 | US6884907 Containing carboxylic acid groups; diagnosis; prophylaxis |
| 04/26/2005 | US6884874 Such as n-methyl-alanine derivatives; for preparing antibody/maytansinoid complexes |
| 04/26/2005 | US6884815 An amino compound containing imidazole and aromatic, or heteroaromatic rings is useful for treating inflammatory and immune system disorders |
| 04/26/2005 | US6884788 Thiol-modified hyaluronan |
| 04/26/2005 | CA2276318C Process for s-aryl-cysteine and derivatives |
| 04/26/2005 | CA2131182C Method for making intermediates useful in synthesis of retroviral protease inhibitors |
| 04/21/2005 | WO2005035565A1 Il-21 derivatives |
| 04/21/2005 | WO2005035553A2 Conjugation of peptides |
| 04/21/2005 | WO2005035514A2 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups |
| 04/21/2005 | WO2005035486A1 2-cyanobenzenesulfonamides for combating animal pests |
| 04/21/2005 | WO2005034988A1 Long-acting molecules in sustained release formulations |
| 04/21/2005 | WO2005034960A1 Treatment of diseases associated with the egr-1 enhancer element |
| 04/21/2005 | WO2005018529A3 Phenoxiacetic acid derivatives |
| 04/21/2005 | WO2004062601A3 Antibacterial agents |
| 04/21/2005 | US20050085645 essentially free of hydroxylamine; essentially free of any solvent; extraction, stripping, free-base release or pH adjustment, and distillation |
| 04/21/2005 | US20050085555 Composition, synthesis and therapeutic applications of polyamines |
| 04/21/2005 | US20050085541 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 04/21/2005 | US20050085503 used for detecting diseases where N-acetylated alpha -linked acidic dipeptidase (NAALADase) levels are altered, effecting neuronal activity, effecting TGF- beta activity, inhibiting angiogenesis, and treating glutamate abnormalities, cancer, pain |
| 04/21/2005 | US20050084452 Deuterated hydrogen in protein, radioactive carbon or nitrogen; bioassay of accurate analyzing the structure of the target high molecular weight protein; producing stable isotope-labeled fumaric acid, tartaric acid through esterification, oxidation, hydrolysis; chemical peptide synthesis |
| 04/21/2005 | CA2542179A1 Il-21 derivatives |
| 04/21/2005 | CA2541590A1 Treatment of diseases associated with the egr-1 enhancer element |
| 04/21/2005 | CA2540978A1 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups |
| 04/21/2005 | CA2539563A1 2-cyanobenzenesulfonamides for combating animal pests |
| 04/20/2005 | EP1196417B1 1,2,3,4,5,6-HEXAHYDROAZEPINO 4,5-b]INDOLES CONTAINING ARYLSULFONES AT THE 9-POSITION |
| 04/20/2005 | EP1165495B1 Resorcinol derivatives |
| 04/20/2005 | EP1089968B1 Thyroid hormone analogues and methods for their preparation |
| 04/20/2005 | CN1608055A Compounds for the treatment of metabolic disorders |
| 04/20/2005 | CN1197475C Chelated feed additive and method of preparation |
| 04/19/2005 | US6881860 Compounds and methods to increase plasma HDL cholesterol levels and improve HDL functionality |
| 04/19/2005 | US6881754 Adamantane derivatives |
| 04/19/2005 | US6881735 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/19/2005 | US6881727 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 04/14/2005 | WO2005033070A2 Method for the production of bisepoxides and dithiols |
| 04/14/2005 | WO2005021493A3 A method of isolating a thiol |
| 04/14/2005 | WO2005009928A3 Preparation and use of alkylating agents |
| 04/14/2005 | US20050080281 Bridged bi-aromatic ligands, catalysts, processes for polymerizing and polymers therefrom |
| 04/14/2005 | US20050080206 Reacting polyethylene glycol with difunctional activator in presence of a tert-aminopyridine base, preferably at room temperature, and under stoichiometric conditions; activators include alkylenebis(sulfuryl halides), alkylenebis(haloformates) and nitrophenoxyalkylene-sulfuryl halides and -haloformates |
| 04/14/2005 | US20050080119 Diaminopropionic acid derivatives |
| 04/14/2005 | US20050080115 Novel compounds, their preparation and use |
| 04/14/2005 | US20050080022 substituted benzylphenol derivatives as intermediates for glucopyranosyloxybenzylbenzene derivatives; agents for the prevention or treatment of diabetes, diabetic complications, obesity or the like |
| 04/14/2005 | DE10343798A1 New 2-thio-1,4-naphthoquinone derivatives, obtained by culturing alpha-Proteobacterium MBIC3368, are angiogenesis inhibitors useful e.g. for combating tumor diseases and neointimal hyperplasia |
| 04/13/2005 | EP1521803A2 Organic thiol metal-free stabilizers and plasticizers for halogen-containing polymers |
| 04/13/2005 | EP1521752A1 Novel macrocycles for the treatment of cancer |
| 04/13/2005 | EP1521741A1 Imaging compounds |
| 04/13/2005 | EP1521740A2 Probucol derivatives |
| 04/13/2005 | CN1606539A Trimerisation and oligomerisation of olefins using a chromium based catalyst |
| 04/13/2005 | CN1606538A Trimerisation and oligomerisation of olefins using a chromium based catalyst |
| 04/13/2005 | CN1196676C Polyisocyanic acid ester |
| 04/12/2005 | US6878828 Coupling cysteine with benzonitrile, then esterifying, alkylating, hydrolyzing and reacting with acids to form 2-methylcysteine |
| 04/12/2005 | US6878823 Substituted and unsubstitued 9-arylsulfone- 1,2,3,4,5,6-hexahydroazepino (4,5-b) indoles are useful in treatment of depression, obesity and other central nervous system disorders |
| 04/12/2005 | US6878750 Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents |
| 04/12/2005 | US6878743 Controlling apoptosis; central nervous system disorders |
| 04/12/2005 | US6878718 Able to inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 04/12/2005 | US6878700 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 04/12/2005 | CA2081836C Aromatic amidine derivatives and salts thereof |
| 04/07/2005 | WO2005030746A1 Calcilytic compounds |
| 04/07/2005 | WO2005030705A1 Inhibitors of histone deacetylase |
| 04/07/2005 | WO2005030704A1 Inhibitors of histone deacetylase |
| 04/07/2005 | WO2005030699A1 Substituted benzanilide compound and pest control agent |
| 04/07/2005 | WO2005030694A1 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 04/07/2005 | WO2005014533A3 Aryl and heteroaryl compounds, compositions, and methods of use |
| 04/07/2005 | WO2005007076A3 Colchicine derivatives |
| 04/07/2005 | WO2004075841A3 Process for preparing benzhydrylthioacetamide |
| 04/07/2005 | US20050075512 Diamine derivatives, process for producing the same, and bactericide containing the same as active ingredient |
| 04/07/2005 | US20050075377 Compounds for elevating plasma lipid levels with prodrugs for humans and other mammals |
| 04/07/2005 | US20050075374 Sulfonyl aryl or heteroaryl hydroxamic acid compounds |
| 04/07/2005 | US20050075294 E.g., 2-(4-Methoxybenzyl)phenyl beta -D-glucopyranoside; inhibitors of human SGLT2 (Na+/glucose cotransporter 2); prevents reabsorption of excess glucose at the kidney, promotes excreting excess glucose though the urine, and normalizes blood glucose level; hypoglycemic and antidiabetic agent; obesity |
| 04/07/2005 | CA2539403A1 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 04/07/2005 | CA2539117A1 Inhibitors of histone deacetylase |
| 04/06/2005 | EP1519917A2 Carbon-11 and fluorine-18 labeled radioligands for positron emission tomography (pet) imaging for the brain serotonin transporters |
| 04/06/2005 | EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators |
| 04/06/2005 | EP1519908A2 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
| 04/06/2005 | EP1227809B1 Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use |
| 04/06/2005 | EP0960096B1 Substituted beta-thiocarboxylic acids |
| 04/06/2005 | CN1604891A Improved methods of ortho alkylation |
| 04/06/2005 | CN1603316A High refractive index, uv-curable monomers and coating compositions prepared therefrom |
| 04/06/2005 | CN1603307A Cyanoacrylate derivatives and their preparation method and biological activity |
| 04/06/2005 | CN1195737C HIV proteinase inhibitor |
| 04/06/2005 | CN1195513C Tocopherols, tocotrienols, other chroman and side chain derivatives and uses |
| 04/05/2005 | US6875893 Preparations of a sulfinyl acetamide |
| 04/05/2005 | US6875884 Urea derivatives as inhibitors for CCR-3 receptor |
| 04/05/2005 | US6875883 Forming a phenyl-thiazoles chemical intermediates for making antioxidants, ferrielectric liquid crystal dopant, picornaviral viricides, antiinflammatory agents, anti-asthma agents, and fibringoen antagonists |
| 04/05/2005 | US6875882 Ferroelectric liquid crystals, antihistamines, antiinflammatory agents, viricides |
| 04/05/2005 | US6875780 Compounds that modulate PPAR activity and methods for their preparation |
| 04/05/2005 | US6875775 Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 04/05/2005 | US6875760 Glucagon antagonists/inverse agonists |
| 04/05/2005 | US6875465 Method of decorating a substrate by application of gold nanoparticles |
| 03/31/2005 | WO2005028430A1 New process for the preparation of a diphenyl ether compound |
| 03/31/2005 | WO2005028429A2 Haloalkyl containing compounds as cysteine protease inhibitors |
| 03/31/2005 | WO2005028426A1 Novel 4-phenylamino-benzaldoxime derivative and use thereof as mek inhibitor |
| 03/31/2005 | WO2004113270A3 Propionic acid derivatives useful in the treatment of lipid disorders |
| 03/31/2005 | WO2004099171A3 Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1b |
| 03/31/2005 | WO2004073606A3 Sulfonamide derivatives as ppar modulators |
| 03/31/2005 | US20050070583 Novel compounds, their preparation and use |
| 03/31/2005 | US20050070582 For example,1-{[2-(3,5-dimethylphenoxy)-5-nitrophenyl]sulfonyl}-4-ethylpiperazine or 1-{[2-(3,5-dichlorophenoxy)-5-nitrophenyl]sulfonyl}piperazine; for the treatment of asthma, atopic dermatitis, allergic rhinitis and other inflammatory/immunological disorders |
| 03/31/2005 | US20050070485 Phenylalanine derivatives |
| 03/31/2005 | US20050070451 Process for making Group II metal overbased sulfurized alkylphenols |
| 03/31/2005 | CA2538115A1 New process for the preparation of a diphenyl ether compound |